In SARS-CoV infection, it has been hypothesized that these antibodies may decrease the rate of infection, and the degree of protection, may be influenced by the ABO antibody titer, secretor status, and incidence of group O in the population [9]. This evidence concerns the gene ABO and severe acute respiratory syndrome.